KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Minority Interest (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Minority Interest for 17 consecutive years, with $33.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Minority Interest fell 37.74% to $33.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $33.0 million, a 37.74% decrease, with the full-year FY2025 number at $33.0 million, down 37.74% from a year prior.
  • Minority Interest was $33.0 million for Q4 2025 at Bristol Myers Squibb, down from $48.0 million in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $71.0 million in Q3 2021 to a low of $33.0 million in Q4 2025.
  • A 5-year average of $58.3 million and a median of $58.5 million in 2024 define the central range for Minority Interest.
  • Peak YoY movement for Minority Interest: grew 3.03% in 2021, then tumbled 37.74% in 2025.
  • Bristol Myers Squibb's Minority Interest stood at $60.0 million in 2021, then fell by 5.0% to $57.0 million in 2022, then dropped by 3.51% to $55.0 million in 2023, then decreased by 3.64% to $53.0 million in 2024, then crashed by 37.74% to $33.0 million in 2025.
  • Per Business Quant, the three most recent readings for BMY's Minority Interest are $33.0 million (Q4 2025), $48.0 million (Q3 2025), and $54.0 million (Q2 2025).